Pfizer breakthrough boosts Thai projectThailand stands to gain from an information-sharing agreement with Pfizer/BioNTech after preliminary results showing its latest Covid-19 vaccine candidate is 90% effective made headlines around the world on Monday. In the Asia-Pacific region, only three countries have supply deals already in place with Pfizer. Dr Nakhon, nevertheless expects researchers in Thailand will benefit as the NVI/Chulalongkorn "mRNA-based vaccine" is similar to Pfizer/BioNTech's. Dr Nakhon said Thai researchers are looking forward to finding out more about the proteins and the processes implemented by Pfizer/BioNTech to recognise them. The world cheered on Monday when Pfizer Inc announced its vaccine, jointly developed with BioNTech SE, was more than 90% effective based on initial trial results.

Source: Bangkok Post November 10, 2020 23:15 UTC